SCHEMBL8957121

SCHEMBL8957121

CCCCc1ncc(C[C@H](NC(=O)CCC)C(=O)O)n1Cc1ccc(C(=O)O)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049832 0.89 — —
SCHEMBL8957152 0.88 AGTR1 (0.61) AGTR1
SCHEMBL8957136 0.87 AGTR1 (0.55) AGTR1
SCHEMBL8957151 0.86 AGTR1 (0.46) AGTR1
SCHEMBL8957116 0.85 AGTR1 (0.57) AGTR1
SCHEMBL7056871 0.83 PTGES (0.44) —
SCHEMBL8971489 0.83 — —
SCHEMBL8971520 0.83 AGTR1 (0.48) AGTR1
SCHEMBL8957293 0.83 AGTR1 (0.53) AGTR1
SCHEMBL8957070 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5565480-A ANGIOTENSIN II RECEPTOR ANTAGONIST; USEFUL IN REGULATING HYPERTENSION, TREATMENT OF CONGESTIVE HEART FAILURE, RENAL FAILURE AND GLUCOMA SMITHKLINE BEECHAM CORPORATION (US) 1996-10-15 — — US disclosed
EP-0536262-A4 SUBSTITUTED HISTIDINES SMITHKLINE BEECHAM CORP (US) 1996-08-14 — — EP disclosed
US-5444081-A Treatment of hypertension, congestive heart failure, renal failure, glaucoma SMITHKLINE BEECHAM CORP (US) 1995-08-22 — — US disclosed
EP-0536262-A1 SUBSTITUTED HISTIDINES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-14 — — EP disclosed
WO-1992000068-A1 SUBSTITUTED HISTIDINES SMITHKLINE BEECHAM CORPORATION (US) 1992-01-09 — — WO disclosed
Send feedback